Press Releases

A new team member

We welcome a new team member to Emplicure - Ingela Sundström. Ingela holds a bachelor of science in Analytical Chemistry and a PhD in Analytical Pharmaceutical Chemistry from Uppsala University. She defended her thesis with the title "Liquid Chromatography-Mass Spectrometry as a Tool for Drug Metabolite Identification in Biological Fluids with Application to Ketobemidone" in 2007. She has previous experience from e.g. Pharmacia, Orexo and Oasmia AB working within development and quality control. At Emplicure Ingela will be responsible for the analytical development.

2021-12-21
Regulatory

Emplicure AB announces today that the Nomination Committee for the annual general shareholders meeting (AGM) in April 2022 is formed. The Nomination Committee consists of representatives nominated by the three largest shareholders per the last bank-day in the third quarter, as well as the Chairman of the Board. Emplicure's three largest shareholders, also the founders, have agreed to vote as one, in order to to give preference for more shareholders.

2021-12-10
Regulatory

Emplicure AB has received issue notification from the US Patent and Trademark Office that a formal approval of the inhalation platform of pharmaceuticals will be issued on December 21, 2021.

2021-11-25
Regulatory

Erik Magnusson appointed new Chief Financial Officer (CFO) in Emplicure AB.

2021-11-19
Regulatory

Following this summer's new share issue and subsequent IPO, we are well equipped. The focus of the third quarter has been on shifting up, and driving the development of the company's two main projects; Empli03, our drug candidate for chronic pain, and Amp01, our oral tobacco-free nicotine product in the form of dry, white pouches as a consumer product. Both projects are developed on our own bioceramic and patented technologies and platforms.

2021-10-06
Regulatorisk

Anna-Lena Nicolson, CFO och medlem i ledningsgruppen i Emplicure AB (publ), har idag beslutat att lämna sitt uppdrag. Anna-Lena kommer att kvarstå som CFO till och med den 31 december 2021. Processen med att rekrytera hennes ersättare har inletts.

2021-09-27
Regulatorisk

Emplicure AB (publ) har anställt Anna Franzén som Sr. Manager Clinical Projects för att driva och utveckla bolagets kliniska projekt.

2021-08-19
Regulatorisk

Emplicure AB (publ) meddelar idag att pantentmyndigheten i USA har utfärdat ett så kallat "Notice of Allowance" avseende Emplicures patentansökan för "Inhalation av läkemedel".

2021-07-14
Regulatorisk

Som tidigare kommunicerats har Emplicure AB (publ) ("Emplicure" eller "Bolaget") genomfört en unitemission av aktier och teckningsoptioner av serie TO1 ("Teckningsoptionerna") i samband med en börsnotering på Nasdaq First North Growth Market. Första dag för handel med Teckningsoptionerna på Nasdaq First North Growth Market är den 19 juli 2021.

1
2
3
4
5

GET STARTED

Do you want to know more?

Contact us today.